Switch theme
Sign up to access all valuation multiples
Harbin Fuerjia Technology Co Ltd is engaged in Research and development, production and sales of professional skin care products. Its products include face masks, toner, lotion, creams and etc.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Harbin Fuerjia Technology has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Harbin Fuerjia Technology achieved revenue of $266M and an EBITDA of $144M.
Harbin Fuerjia Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Harbin Fuerjia Technology valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $266M | n/a | XXX | XXX | XXX |
| Gross Profit | $186M | $203M | XXX | XXX | XXX |
| Gross Margin | 70% | NaN% | XXX | XXX | XXX |
| EBITDA | $144M | n/a | XXX | XXX | XXX |
| EBITDA Margin | 54% | NaN% | XXX | XXX | XXX |
| Net Profit | $111M | $117M | XXX | XXX | XXX |
| Net Margin | 42% | NaN% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Harbin Fuerjia Technology's stock price is CNY 33 (or $4).
Harbin Fuerjia Technology has current market cap of CNY 13.1B (or $1.8B), and EV of CNY 10.1B (or $1.4B).
See Harbin Fuerjia Technology trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.8B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Harbin Fuerjia Technology has market cap of $1.8B and EV of $1.4B.
Harbin Fuerjia Technology's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Harbin Fuerjia Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Harbin Fuerjia Technology and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.4B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHarbin Fuerjia Technology's NTM/LTM revenue growth is n/a
Harbin Fuerjia Technology's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Harbin Fuerjia Technology's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Harbin Fuerjia Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Harbin Fuerjia Technology and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 28% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 35% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Harbin Fuerjia Technology acquired XXX companies to date.
Last acquisition by Harbin Fuerjia Technology was XXXXXXXX, XXXXX XXXXX XXXXXX . Harbin Fuerjia Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Harbin Fuerjia Technology founded? | Harbin Fuerjia Technology was founded in 2017. |
| Where is Harbin Fuerjia Technology headquartered? | Harbin Fuerjia Technology is headquartered in China. |
| Is Harbin Fuerjia Technology publicy listed? | Yes, Harbin Fuerjia Technology is a public company listed on SHE. |
| What is the stock symbol of Harbin Fuerjia Technology? | Harbin Fuerjia Technology trades under 301371 ticker. |
| When did Harbin Fuerjia Technology go public? | Harbin Fuerjia Technology went public in 2023. |
| Who are competitors of Harbin Fuerjia Technology? | Similar companies to Harbin Fuerjia Technology include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Harbin Fuerjia Technology? | Harbin Fuerjia Technology's current market cap is $1.8B |
| Is Harbin Fuerjia Technology profitable? | Yes, Harbin Fuerjia Technology is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
